From: Cost-effectiveness of CTA, MRA and DSA in patients with non-traumatic subarachnoid haemorrhage
 | MRA | CTA | DSA | |||
---|---|---|---|---|---|---|
Costs (€) | QALYs | Costs (€) | QALYs | Costs (€) | QALYs | |
MRA resp. CTA | 252 | 0.5947 | 197 | 0.5983 | Â | 0.6039 |
DSA | 168a | Â | 214a | Â | 725 | Â |
 Total diagnostic | 420 |  | 411 |  | 725 |  |
Treatment | 26,734 | Â | 26,120 | Â | 25,553 | Â |
Death | 217 | Â | 212 | Â | 205 | Â |
Disability costs | 14,443 | Â | 14,005 | Â | 13,325 | Â |
 Total | 41,814 | 0.5947 | 40,748 | 0.5983 | 39,808 | 0.6039 |